The challenge
Chronic conditions like heart failure (HF) and pulmonary arterial hypertension (PAH) have a severe negative impact on patients’ quality of life but are also among the largest sources of healthcare costs in the world.
Without optimal medication, HF and PAH patients cycle downward, experiencing multiple rehospitalizations where they fight for their lives and generate large medical costs.